低风险组织学表现的原发性甲状腺癌伴远处转移:临床病理与分子特征
该研究对缺乏广泛甲状腺外侵犯、广泛血管侵犯或显著淋巴结转移但出现远处转移的高分化甲状腺癌队列进行临床病理回顾和靶向二代测序。此类低风险组织学表现伴远处转移仅占转移性非未分化甲状腺癌的3%,15例均初诊即有远处转移,多数为包裹型滤泡型甲状腺乳头状癌且仅包膜侵犯,TERT启动子突变高频出现。
要点
- 低风险组织学表现的原发性甲状腺癌伴远处转移罕见,占转移性非未分化甲状腺癌的3%。
- 15例均初诊即发现远处转移,多数为包裹型滤泡型甲状腺乳头状癌(8例)且仅包膜侵犯。
- 二代测序8例中RAS突变5例、TERT启动子突变6例,TERT启动子突变率高于一般PTC。
核心结论
- 低风险组织学表现的原发性甲状腺癌出现远处转移时几乎均在初诊时发现。
- 多数为仅包膜侵犯的包裹型滤泡型甲状腺乳头状癌。
- TERT启动子突变发生率高于一般PTC,可能有助于解释这些组织学上具有欺骗性的原发癌的侵袭行为。
研究设计与样本
- 对缺乏广泛甲状腺外侵犯、广泛血管侵犯或显著淋巴结转移但出现远处转移的高分化甲状腺癌队列进行详细临床病理回顾和靶向二代测序。
主要发现
- 低风险组织学特征伴远处转移的原发性高分化甲状腺癌仅占转移性非未分化甲状腺癌的3%。
- 15例符合纳入标准者均初诊即有远处转移,其中11/15为滤泡型甲状腺乳头状癌,包裹型8例。
- 其余为包裹型Hürthle细胞癌2例、包裹型滤泡癌1例、包裹型经典型乳头状癌1例。
- 12例包裹型癌中10例仅有包膜侵犯而无血管侵犯,92%的肿瘤显示广泛瘤内纤维化。
- 8例行二代测序者中RAS突变5/8为主要驱动,TERT启动子突变6/8,4例TERT启动子突变伴RAS或BRAF突变,BRAF突变经典型乳头状癌1/8。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Distant metastases (DM) are a rare occurrence in well-differentiated thyroid carcinoma. The aim of this study was to analyze the clinical, pathologic, and molecular features of primary thyroid carcinoma with low-risk histology that develop DM. METHODS: A detailed clinicopathologic review and targeted next-generation sequencing were performed on a cohort of well-differentiated thyroid carcinoma lacking gross extrathyroidal extension, extensive vascular invasion, or significant lymph node metastases but exhibiting DM. RESULTS: Primary well-differentiated thyroid carcinoma with low-risk histologic features and DM was a rare occurrence, accounting for only 3% of metastatic non-anaplastic thyroid carcinoma. All 15 cases meeting the inclusion criteria harbored DM at presentation. The majority (11/15) of these tumors were follicular variant of papillary thyroid carcinoma (PTC), especially the encapsulated form (n = 8). The remaining patients harbored encapsulated Hürthle cell carcinoma (n = 2), encapsulated follicular carcinoma (n = 1), and an encapsulated papillary carcinoma classical variant (n = 1). Of the 12 encapsulated carcinomas, 10 had capsular invasion only and no vascular invasion. Ninety-two percent of the tumors exhibited extensive intra-tumoral fibrosis. Among the eight tumors that were subjected to next-generation sequencing analysis, a RAS mutation was the main driver (5/8), and TERT promoter mutation was highly prevalent (6/8). In four cases, TERT promoter mutations were associated with RAS or BRAF mutations. BRAF-mutated classical variant of papillary carcinoma also presented with DM but was less common (1/8). In 11/15 cases, the clinician was able to diagnose distant disease based on the clinical presentation. In 3/4 incidental cases that were genotyped, TERT promoter mutations were found. CONCLUSIONS: When DM occur in primary thyroid carcinoma with low-risk histology, they are almost always found at presentation. The majority are encapsulated follicular variant of PTC with capsular invasion only. TERT promoter mutations occur at a higher rate than that seen in PTC in general and may help explain the aggressive behavior of these histologically deceptive primary carcinomas.
引用
- Xu B, Tuttle RM, Sabra MM, et al. Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics. Thyroid. 2017. PMID: 28049366. doi:10.1089/thy.2016.0582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。